Image de couverture de livre

COVID-19 and immunological regulations: from basic and translational aspects to clinical implications

Afficher d'autres versions (1)

The COVID-19 pandemic caused by SARS-CoV-2 has far-reaching direct and indirect medical consequences. These include both the course and treatment of diseases. It is becoming increasingly clear that infections with SARS-CoV-2 can cause considerable immunological alterations, which particularly also a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Schön, Michael (Auteur) , Berking, Carola (Auteur) , Biedermann, Tilo (Auteur) , Buhl, Timo (Auteur) , Erpenbeck, Luise (Auteur) , Eyerich, Kilian (Auteur) , Eyerich, Stefanie (Auteur) , Ghoreschi, Kamran (Auteur) , Goebeler, Matthias (Auteur) , Ludwig, Ralf (Auteur) , Schäkel, Knut (Auteur) , Schilling, Bastian (Auteur) , Schlapbach, Christoph (Auteur) , Stary, Georg (Auteur) , Stebut-Borschitz, Esther von (Auteur) , Steinbrink, Kerstin (Auteur)
Format: Article (Journal)
Langue:anglais
Publié: 21 August 2020
In: Journal der Deutschen Dermatologischen Gesellschaft
Year: 2020, Volume: 18, Numéro: 8, Pages: 795-807
ISSN:1610-0387
DOI:10.1111/ddg.14169
Accès en ligne:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/ddg.14169
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ddg.14169
Accéder au texte intégral
Notes sur l'auteur:Michael P. Schön, Carola Berking, Tilo Biedermann, Timo Buhl, Luise Erpenbeck, Kilian Eyerich, Stefanie Eyerich, Kamran Ghoreschi, Matthias Goebeler, Ralf J. Ludwig, Knut Schäkel, Bastian Schilling, Christoph Schlapbach, Georg Stary, Esther von Stebut, Kerstin Steinbrink
Description
Résumé:The COVID-19 pandemic caused by SARS-CoV-2 has far-reaching direct and indirect medical consequences. These include both the course and treatment of diseases. It is becoming increasingly clear that infections with SARS-CoV-2 can cause considerable immunological alterations, which particularly also affect pathogenetically and/or therapeutically relevant factors. Against this background we summarize here the current state of knowledge on the interaction of SARS-CoV-2/COVID-19 with mediators of the acute phase of inflammation (TNF, IL-1, IL-6), type 1 and type 17 immune responses (IL-12, IL-23, IL-17, IL-36), type 2 immune reactions (IL-4, IL-13, IL-5, IL-31, IgE), B-cell immunity, checkpoint regulators (PD-1, PD-L1, CTLA4), and orally druggable signaling pathways (JAK, PDE4, calcineurin). In addition, we discuss in this context non-specific immune modulation by glucocorticosteroids, methotrexate, antimalarial drugs, azathioprine, dapsone, mycophenolate mofetil and fumaric acid esters, as well as neutrophil granulocyte-mediated innate immune mechanisms. From these recent findings we derive possible implications for the therapeutic modulation of said immunological mechanisms in connection with SARS-CoV-2/COVID-19. Although, of course, the greatest care should be taken with patients with immunologically mediated diseases or immunomodulating therapies, it appears that many treatments can also be carried out during the COVID-19 pandemic; some even appear to alleviate COVID-19.
Description:Gesehen am 06.07.2026
Description matérielle:Online Resource
ISSN:1610-0387
DOI:10.1111/ddg.14169

Documents similaires